no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
|
Scartozzi, Mario |
|
2016 |
11 |
4 |
p. 489-500 |
article |
2 |
Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy
|
Bondon-Guitton, E. |
|
2016 |
11 |
4 |
p. 549-552 |
article |
3 |
French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends
|
Chouaid, Christos |
|
2016 |
11 |
4 |
p. 515-534 |
article |
4 |
Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints
|
Alsina, Maria |
|
2016 |
11 |
4 |
p. 469-477 |
article |
5 |
Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?
|
Faivre, Sandrine |
|
2016 |
11 |
4 |
p. 565-567 |
article |
6 |
Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia
|
Madhumathi, Jayaprakasam |
|
2016 |
11 |
4 |
p. 535-547 |
article |
7 |
Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report
|
Dooley, Andrew J. |
|
2016 |
11 |
4 |
p. 557-563 |
article |
8 |
Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts
|
Rolff, J. |
|
2016 |
11 |
4 |
p. 507-514 |
article |
9 |
Ramucirumab Clinical Development: an Emerging Role in Gastrointestinal Tumors
|
Sanchez-Gastaldo, Amparo |
|
2016 |
11 |
4 |
p. 479-487 |
article |
10 |
Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis
|
Hu, Chenxi |
|
2016 |
11 |
4 |
p. 501-505 |
article |
11 |
Severe Hyponatremia and Immune Nephritis Following an Initial Infusion of Nivolumab
|
Vandiver, Jeremy W. |
|
2016 |
11 |
4 |
p. 553-556 |
article |
12 |
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: ‘Game Over’?
|
Modena, Alessandra |
|
2016 |
11 |
4 |
p. 431-446 |
article |
13 |
The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development
|
Gong, Jun |
|
2016 |
11 |
4 |
p. 447-467 |
article |